PU.1 Is Identified as a Novel Metastasis Suppressor in Hepatocellular Carcinoma Regulating the miR-615-5p/IGF2 Axis |
Song, Li-Jie
(Department of Oncology, the First Affiliated Hospital of Zhengzhou University)
Zhang, Wei-Jie (Department of Oncology, the First Affiliated Hospital of Zhengzhou University) Chang, Zhi-Wei (Department of Oncology, the First Affiliated Hospital of Zhengzhou University) Pan, Yan-Feng (Department of Oncology, the First Affiliated Hospital of Zhengzhou University) Zong, Hong (Department of Oncology, the First Affiliated Hospital of Zhengzhou University) Fan, Qing-Xia (Department of Oncology, the First Affiliated Hospital of Zhengzhou University) Wang, Liu-Xing (Department of Oncology, the First Affiliated Hospital of Zhengzhou University) |
1 | Kutay H, Bai S, Datta J, et al (2006). Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem, 99, 671-8. DOI |
2 | Landgraf P, Rusu M, Sheridan R, et al (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell, 129, 1401-14. DOI |
3 | Lin L, Pang W, Chen K, et al (2012). Adipocyte expression of PU. 1 transcription factor causes insulin resistance through upregulation of inflammatory cytokine gene expression and ROS production. Am J Physiol-Endoc M, 302, 1550-9. |
4 | Liu AM, Xu Z, Shek FH, et al (2014). miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma. PloS one, 9, 86872. DOI |
5 | Llovet JM, Hernandez-Gea V (2014). Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design. Clin Cancer Res, 20, 2072-9. DOI |
6 | Loffreda S, Yang S, Lin H, et al (1998). Leptin regulates proinflammatory immune responses. FASEB J, 12, 57-65. |
7 | Metcalf D, Dakic A, Mifsud S, et al (2006). Inactivation of PU. 1 in adult mice leads to the development of myeloid leukemia. Proc Natl Acad Sci USA, 103, 1486-91. DOI |
8 | Olena AF, Patton JG (2014). MiRNA biogenesis and function. in: microRNA in development and in the progression of cancer, pp, 3-28. |
9 | Pang WJ, Lin LG, Xiong Y, et al (2013). Knockdown of PU. 1 AS lncRNA inhibits adipogenesis through enhancing PU. 1 mRNA translation. J Cell Biochem, 114, 2500-12. DOI |
10 | Shimizu S, Takehara T, Hikita H, et al (2010). The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol, 52, 698-704. DOI |
11 | Toiyama Y, Tanaka K, Kitajima T, et al (2014). Elevated serum angiopoietin-like protein 2 correlates with the metastatic properties of colorectal cancer: a serum biomarker for early diagnosis and recurrence. Clin Cancer Res, 20, 6175-86. DOI |
12 | Wang F, Tong Q (2008). Transcription factor PU. 1 is expressed in white adipose and inhibits adipocyte differentiation. Am J Physiol-Cell Ph, 295, 213-20. DOI |
13 | Wei N, Pang W, Wang Y, et al (2014). Knockdown of PU. 1 mRNA and AS lncRNA regulates expression of immune-related genes in zebrafish danio rerio. Dev Comp Immunol, 44, 315-9. DOI |
14 | Wei N, Wang Y, Xu RX, et al (2015). PU. 1 antisense lncRNA against its mRNA translation promotes adipogenesis in porcine preadipocytes. Anim Genet, 46, 133-40. DOI |
15 | Bruix J, Sherman M (2011). Management of hepatocellular carcinoma: an update. Hepatol, 53, 1020-2. DOI |
16 | Christie DA, Xu LS, Turkistany SA, et al (2015). PU. 1 opposes IL-7-dependent proliferation of developing B cells with involvement of the direct target gene bruton tyrosine kinase. J Immunol, 194, 595-605. DOI |
17 | Drusco A, Nuovo GJ, Zanesi N, et al (2014). MicroRNA profiles discriminate among colon cancer metastasis. PloS one, 9, 96670. DOI |
18 | El Tayebi H, Hosny K, Esmat G, Breuhahn K, Abdelaziz AI (2012). MiR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma. FEBS Lett, 586, 3309-16. DOI |
19 | Fornari F, Gramantieri L, Giovannini C, et al (2009). MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res, 69, 5761-7. DOI |
20 | Guan J (2015). Cholesterol-conjugated let-7a miRNA mimics: promising tools for HCC systemic. RNA and DISEASE, 2, doi.org/10.14800/rd.630. DOI |
21 | Kudo M, Matsui O, Izumi N, et al (2014). JSH consensusbased clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the liver cancer study group of Japan. Liver Cancer, 3, 458-68. DOI |